These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7732817)

  • 21. Enteric-coated aspirin and cyclooxygenase inhibition.
    Svensson J; Mettinger KL; Blombäck M
    Thromb Res; 1983 Jan; 29(1):99-102. PubMed ID: 6404001
    [No Abstract]   [Full Text] [Related]  

  • 22. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide.
    Nüsing RM; Reinalter SC; Peters M; Kömhoff M; Seyberth HW
    Clin Pharmacol Ther; 2001 Oct; 70(4):384-90. PubMed ID: 11673754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enteric-coated aspirin, platelet cyclooxygenase activity and function.
    Rao GH; Radh E; Johnson GJ; White JG
    Prostaglandins Leukot Med; 1984 Mar; 13(3):341-7. PubMed ID: 6425869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salicylamide reverses the aspirin-antagonistic effect of salicylic acid on rat platelet cyclooxygenase.
    Rizk M; Abdel-Rahman MS
    Prostaglandins Leukot Essent Fatty Acids; 1994 Nov; 51(5):363-7. PubMed ID: 7846108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resolution of prostaglandin endoperoxide synthase and thromboxane synthase of human platelets.
    Hammarström S; Falardeau P
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3691-5. PubMed ID: 410024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can hemodialysis remove the factor that suppresses platelet cyclo-oxygenase activity in uremic patients?
    Tanaka H; Umimoto K; Izumi N; Maekawa T; Kishimoto T; Maekawa M
    Trans Am Soc Artif Intern Organs; 1985; 31():552-5. PubMed ID: 3939277
    [No Abstract]   [Full Text] [Related]  

  • 28. Activation of platelet cyclooxygenase by red cells in vitro.
    Violi F; Ghiselli A; Alessandri C; Frattaroli S; Iuliano L; Balsano F
    N Engl J Med; 1985 Oct; 313(17):1091-2. PubMed ID: 3930963
    [No Abstract]   [Full Text] [Related]  

  • 29. Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems.
    Giuliano F; Warner TD
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1001-6. PubMed ID: 12438520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Indicators of prostaglandin synthase activity in thrombocytes of patients with schizophrenia with positive and negative disorders].
    Geling NG; Klimenko TV; Milekhin GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(4):99-101. PubMed ID: 1650110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cyclooxygenases inhibitors on vasoactive prostanoids and thrombin generation at the site of microvascular injury in healthy men.
    Tuleja E; Mejza F; Cmiel A; Szczeklik A
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1111-5. PubMed ID: 12730088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanism of changes in the platelet functional activity caused by low energy laser irradiation].
    Spasov AA; Nedogoda VV; Konan K
    Biull Eksp Biol Med; 1998 Jul; 126(7):45-8. PubMed ID: 9777195
    [No Abstract]   [Full Text] [Related]  

  • 33. Selective cyclooxygenase-2 inhibition by nimesulide in man.
    Cullen L; Kelly L; Connor SO; Fitzgerald DJ
    J Pharmacol Exp Ther; 1998 Nov; 287(2):578-82. PubMed ID: 9808683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible inconsistencies in study on cyclooxygenase.
    Kay-Mugford T; Conlon P
    Am J Vet Res; 1999 Mar; 60(3):275-6. PubMed ID: 10188806
    [No Abstract]   [Full Text] [Related]  

  • 35. Human pharmacology of naproxen sodium.
    Capone ML; Tacconelli S; Sciulli MG; Anzellotti P; Di Francesco L; Merciaro G; Di Gregorio P; Patrignani P
    J Pharmacol Exp Ther; 2007 Aug; 322(2):453-60. PubMed ID: 17473175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A method for estimating prostaglandin synthetase activity in blood platelets and the extent of its pharmacological inhibition [proceedings].
    Cockbill SR; Heptinstall S
    J Physiol; 1978 Mar; 276():15P-16P. PubMed ID: 418169
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal.
    Di Nunno L; Vitale P; Scilimati A; Tacconelli S; Patrignani P
    J Med Chem; 2004 Sep; 47(20):4881-90. PubMed ID: 15369392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers.
    Wilner KD; Rushing M; Walden C; Adler R; Eskra J; Noveck R; Vargas R
    J Clin Pharmacol; 2002 Sep; 42(9):1027-30. PubMed ID: 12211219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity.
    Ali M; McDonald JW
    Prostaglandins Med; 1979 Dec; 3(6):327-32. PubMed ID: 121613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Endoperoxide prostaglandin synthetase from the microsomal fraction of human platelets].
    Mevkh AT; Basevich VV; Varfolomeev SD
    Biokhimiia; 1982 Oct; 47(10):1635-40. PubMed ID: 6816299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.